Community Shares | July 8th 2024
A new review has investigated the potential use of immunomodulating agents to treat neuroinflammation in patients with autism, who often do not respond to standard treatments. Neuroinflammation, influenced by genetic, epigenetic, and environmental factors, is considered a significant contributor to ASD. This work highlights that some existing anti-inflammatory treatments have shown promise, including corticosteroids, intravenous […]
Study Finds More Intensive Autism Interventions Do Not Guarantee Better Outcomes
New Research Suggests Tailored, Developmentally Appropriate Approaches May Be More Effective for Young Children with Autism A new study led by the UNC School of Medicine and researchers across the country has found that higher-intensity interventions do not necessarily yield better outcomes for young children with autism. The meta-analysis, published in JAMA Pediatrics, reviewed data […]
The Wall Street Journal Reports on Record Surge in Special Education Enrollment, Straining U.S. Schools
Pandemic Disruptions and Reduced Stigma Drive Increase in Autism and Other Diagnoses A Wall Street Journal article highlights the recent surge in special education enrollments, driven by pandemic disruptions and reduced stigma, leaving U.S. schools struggling to meet the needs of a record 7.5 million students requiring these services. This increase, now comprising 15.2% of […]
Community Shares | July 1st 2024
A new study has investigated factors influencing the age at which mothers first became concerned about their child’s development and the subsequent time it took to start services for children with autism. Analyzing 759 preschool-aged children with ASD, the researchers found that earlier maternal concerns were linked to having multiple children, the presence of a […]
Researchers Document Reversal of Severe Autism Diagnoses in Twins Through Comprehensive Treatment
Environmental and Lifestyle Modifications, Including Dietary Changes and Vision Therapy, Show Significant and Sustained Improvements A new case series from a team of researchers, including Dr. Richard Frye, has documented the reversal of Level 3 (i.e., requiring very substantial support) Autism Spectrum Disorder diagnoses in dizygotic toddler twin girls over a two-year period primarily through […]
CBD and Metformin Found to Alleviate Behavioral Issues in Autism-Linked Syndromes
New Study Shows Promising Results in Mouse Models, Highlighting Potential for Long-Term Human Treatments Recent research presented at the Federation of European Neuroscience Societies (FENS) Forum 2024 has found that cannabidiol (CBD) and metformin can alleviate behavioral difficulties in mouse models of Fragile X and Phelan-McDermid syndromes, both of which are linked to autism spectrum […]
